CARDIOLOGY CLINICS
ISSN:0733-8651

CARDIOLOGY CLINICS

CARDIOL CLIN
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:>12周,或约稿
新锐分区:医学4区
年发文量:46
影响因子:1.6
JCR分区:Q3

基本信息

《心脏病学临床》每年出版四期,分别于2月、5月、8月和11月出版,为您提供最新的患者管理趋势,让您了解最新进展,并为选择治疗方案提供可靠的依据。为满足心脏病学领域的需求,每期都集中在一个心脏病学主题上,包括急性冠状动脉综合征/心脏急症、冠状动脉疾病、心力衰竭、心律失常等。
0733-8651SCIE/Scopus收录
1.6
1.3
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q3
146/231
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
Q3
119/231
50
46
-容易>12周,或约稿-医学-心血管系统
0%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
97.83%1.42%-
CiteScore:4.60
SJR:0.821
SNIP:1.043
学科类别分区排名百分位
大类:Medicine
小类:Cardiology and Cardiovascular Medicine
Q2
134 / 397

期刊高被引文献

Cardiotoxicity of Immune Therapy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.008
Genetic Testing and Counseling for Hypertrophic Cardiomyopathy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.003
Cardiorenal Syndrome: Pathophysiology.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.04.001
Hypertensive Disorders of Pregnancy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.04.008
Pathophysiology of Atrial Fibrillation and Heart Failure: Dangerous Interactions.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.002
Cardiac Magnetic Resonance for Diagnosis and Risk Stratification.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.002
Surgical Myectomy: Subaortic, Midventricular, and Apical.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.006
Cardiovascular Toxicities in Pediatric Cancer Survivors.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.002
Hypertensive Emergencies: A Review of Common Presentations and Treatment Options.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.003
Advanced Heart Failure Management and Transplantation.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.007
Approach to Surgery for Cardiac Tumors: Primary Simple, Primary Complex, and Secondary.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.001
Echocardiography in the Diagnosis and Management of Hypertrophic Cardiomyopathy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.09.001
Carcinoid Heart Disease: A Guide for Clinicians.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.014
Apolipoprotein L1, Cardiovascular Disease and Hypertension: More Questions than Answers.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.009
Fluoropyrimidine-Associated Cardiotoxicity.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.004
Anthracycline Cardiotoxicity: It Is Possible to Teach an Old Dog Some New Tricks.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.08.001
Prediction and Management of Recurrences after Catheter Ablation in Atrial Fibrillation and Heart Failure.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.010
Historical Perspectives in the Evolution of Hypertrophic Cardiomyopathy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.001
Acute Kidney Injury, Heart Failure, and Health Outcomes.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.005
Novel Ablation Approaches for Challenging Atrial Fibrillation Cases (Mapping, Irrigation, and Catheters).
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.01.012
Treatment of Cardiorenal Syndrome.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.002
Trastuzumab-Induced Cardiomyopathy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.005
Diagnosis and Treatment of Cardiac Amyloidosis Related to Plasma Cell Dyscrasias.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.013
Arrhythmogenic Anticancer Drugs in Cardio-Oncology.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.011
Common Vascular Toxicities of Cancer Therapies.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.003
Cardiotoxicity Related to Radiation Therapy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.010
Cardiomyopathy Prevention in Cancer Patients.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.009
Role of Cardiovascular Biomarkers in the Risk Stratification, Monitoring, and Management of Patients with Cancer.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.015
Choice of Septal Reduction Therapies and Alcohol Septal Ablation.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.009
MRI of Cardiotoxicity.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.007
Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.004
Echocardiography Imaging of Cardiotoxicity.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.006
Tackling Patient-Reported Outcomes in Atrial Fibrillation and Heart Failure: Identifying Disease-Specific Symptoms?
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.01.013
Imaging for Risk Stratification in Atrial Fibrillation with Heart Failure.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.007
Novel Antidiabetic Therapies and Cardiovascular Risk Reduction: The Role of the Noninferiority Trial.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.007
Hypertension Management in Chronic Kidney Disease and Diabetes: Lessons from the Systolic Blood Pressure Intervention Trial.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.006
Contrast Nephropathy Associated with Percutaneous Coronary Angiography and Intervention.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.004
Atrial Fibrillation in Heart Failure: Left Atrial Appendage Management.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.009
Sudden Cardiac Death in End-Stage Renal Disease.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.04.010
Sudden Cardiac Death Risk Stratification and the Role of the Implantable Cardiac Defibrillator.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.011
Cardiac Interventional Procedures in Cardio-Oncology Patients.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.012
Implementing a Cardio-oncology Center of Excellence: Nuts and Bolts, Including Coding and Billing.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.07.016
Should His Bundle Pacing Be Preferred over Cardiac Resynchronization Therapy Following Atrioventricular Junction Ablation?
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.006
Randomized Clinical Trials of Catheter Ablation of Atrial Fibrillation in Congestive Heart Failure: Knowns and Unmet Needs.
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.003
Arrhythmia Evaluation and Management.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.005
Role of Advanced Testing: Invasive Hemodynamics, Endomyocardial Biopsy, and Cardiopulmonary Exercise Testing.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.010
Does Left Ventricular Systolic Function Matter? Treating Atrial Fibrillation in HFrEF Versus HFpEF.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.01.008
Novel Pharmacotherapy for Hypertrophic Cardiomyopathy.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2018.08.008
Mechanisms of Improved Mortality Following Ablation: Does Ablation Restore Beta-Blocker Benefit in Atrial Fibrillation/Heart Failure?
来源期刊:Cardiology clinicsDOI:10.1016/J.CCL.2019.01.011
Atrial Fibrillation Ablation Should Be First-Line Therapy in Heart Failure Patients: CON.
来源期刊:Cardiology clinicsDOI:10.1016/j.ccl.2019.01.005

相关文章

2026年3月发布(新锐分区)
大类学科小类学科Top期刊综述期刊
医学4区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
4区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统
3区